Detection of gene mutations related with drug resistance inMycobacterium lepraefrom leprosy patients using Touch-Down (TD) PCR
Open Access
- 1 May 2003
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 36 (1-2) , 27-32
- https://doi.org/10.1016/s0928-8244(03)00038-5
Abstract
The lack of methods to identify Mycobacterium leprae with the resistance against multi-drugs quickly and specifically has hindered effective chemotheKeywords
This publication has 16 references indexed in Scilit:
- Multidrug Resistant Mycobacterium leprae from Patients with LeprosyAntimicrobial Agents and Chemotherapy, 2001
- The prevalence offolP1mutations associated with clinical resistance to dapsone, inMycobacterium lepraeisolates from South KoreaPathogens and Global Health, 2001
- PCR primers that can detect low levels of Mycobacterium leprae DNAJournal of Medical Microbiology, 2001
- Dihydropteroate Synthase of Mycobacterium leprae and Dapsone ResistanceAntimicrobial Agents and Chemotherapy, 2000
- Diaminodiphenylsulfone resistance ofMycobacterium lepraedue to mutations in the dihydropteroate synthase geneFEMS Microbiology Letters, 1999
- Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 updateTubercle and Lung Disease, 1998
- Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium lepraeThe Lancet, 1997
- Clinical trial of fusidic acid for lepromatous leprosyAntimicrobial Agents and Chemotherapy, 1994
- ‘Touchdown’ PCR to circumvent spurious priming during gene amplificationNucleic Acids Research, 1991
- Specific identification of Mycobacterium leprae by the polymerase chain reactionMolecular and Cellular Probes, 1990